Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training
Ex Onc SLED: a Pilot Study Utilizing a Weighted Sled for Horizontal Resistance Training
1 other identifier
observational
30
1 country
1
Brief Summary
This protocol seeks to analyze patient adherence and outcomes after monitored exercise sessions utilizing primarily weighted sled pushes and pulls for linearly progressed resistance training of individuals who have been diagnosed with cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2024
CompletedFirst Submitted
Initial submission to the registry
September 20, 2024
CompletedFirst Posted
Study publicly available on registry
September 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 18, 2026
February 26, 2025
February 1, 2025
2 years
September 20, 2024
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Adipose Tissue (InBody, kg)
Change in adipose tissue (kg) pre and post resistance training regimen measured via InBody 970 bioelectrical impedance analysis
Baseline and study completion, up to 6 months.
Change in Adipose Tissue (Ultrasound, Lbs)
Change in adipose tissue (pounds) pre and post resistance training regimen measured via ultrasound.
Baseline and study completion, up to 6 months.
Change in Muscle Mass
Changes in percent muscle mass (measured by InBody bioelectrical impedance analysis) and percent fat-free mass (measured by ultrasound) from baseline to six months
Baseline and study completion, up to 6 months.
Secondary Outcomes (12)
Intervention Compliance Rate during Exercise Program (Adherence)
Through study completion, up to 6 months.
Feasibility of the Exercise Program
Through study completion, up to 6 months.
Adverse Events (Safety)
Through study completion, up to 6 months.
Changes in Timed Up and Go Test Performance at baseline and post-exercise assessment
Baseline and study completion, up to 6 months.
Changes in Functional Mobility Score at baseline and post-exercise assessment
Baseline and study completion, up to 6 months.
- +7 more secondary outcomes
Eligibility Criteria
Individuals diagnosed with cancer on an exercise program at the AHN Exercise Oncology and Resiliency Center
You may qualify if:
- Age 20-89 years
- Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study.
- Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI and must be able to stand.
- Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. Any individuals not deemed safe to participate in the basic EOC exercise program will be referred to physical therapy or elsewhere
You may not qualify if:
- Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program
- Individuals deemed able to engage in more intense resistance training utilizing compound movements will not be eligible
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colin Champ, MD
AHN Radiation Oncology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Radiation Oncologist
Study Record Dates
First Submitted
September 20, 2024
First Posted
September 24, 2024
Study Start
June 18, 2024
Primary Completion (Estimated)
June 18, 2026
Study Completion (Estimated)
September 18, 2026
Last Updated
February 26, 2025
Record last verified: 2025-02